Search

Your search keyword '"Rui-Xia Xu"' showing total 9 results
Start Over Author "Rui-Xia Xu" Journal journal of the american college of cardiology
9 results on '"Rui-Xia Xu"'

1. PROGNOSTIC VALUE OF HEART-TYPE FATTY ACID BINDING PROTEIN COMPARED TO TROPONIN I IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE: A LARGE COHORT WITH LONG-TERM FOLLOW-UP STUDY

Author

Jing-Lu Jin, Ying Gao, Hui-Wen Zhang, Qian Dong, Hui-Hui Liu, Jing Sun, Rui-Xia Xu, Ye-Xuan Cao, Cheng-Gang Zhu, Jian-Jun Li, Yuan-Lin Guo, and Na-Qiong Wu

Subjects
medicine.medical_specialty, business.industry, Long term follow up, medicine.disease, Large cohort, Coronary artery disease, Heart-type fatty acid binding protein, Internal medicine, Troponin I, Cardiology, Medicine, In patient, Cardiology and Cardiovascular Medicine, business, Value (mathematics)
Published
2020

2. IMPACT OF RESIDUAL CHOLESTEROL ON PROGNOSIS IN CORONARY ARTERY DISEASE PATIENTS UNDER DIFFERENT GLUCOSE METABOLISM STATUS

Author

Ying Gao, Na-Qiong Wu, Ye-Xuan Cao, Hui-Hui Liu, Qian Dong, Yuan-Lin Guo, Jing Sun, Rui-Xia Xu, Cheng-Gang Zhu, Jing-Lu Jin, Hui-Wen Zhang, Chuan-Jue Cui, and Jian-Jun Li

Subjects
Coronary artery disease, chemistry.chemical_compound, medicine.medical_specialty, chemistry, business.industry, Cholesterol, Internal medicine, Cardiology, Medicine, Carbohydrate metabolism, Cardiology and Cardiovascular Medicine, business, medicine.disease
Published
2020

3. HEART-TYPE FATTY ACID BINDING PROTEIN RATHER THAN TROPONIN I ASSOCIATES WITH INCREASED RISK OF MYOCARDIAL INJURY AND ADVERSE EVENTS IN PATIENTS RECEIVING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION

Author

Yuan-Lin Guo, Qian Dong, Jian-Jun Li, Ying Gao, Rui-Xia Xu, Jing Sun, Na-Qiong Wu, Ye-Xuan Cao, Jing-Lu Jin, Hui-Hui Liu, Cheng-Gang Zhu, and Hui-Wen Zhang

Subjects
medicine.medical_specialty, business.industry, medicine.medical_treatment, Percutaneous coronary intervention, medicine.disease, Fatty acid-binding protein, Coronary artery disease, Heart-type fatty acid binding protein, Internal medicine, Troponin I, Conventional PCI, medicine, Cardiology, In patient, cardiovascular diseases, Cardiology and Cardiovascular Medicine, Adverse effect, business
Abstract

Myocardial injury after percutaneous coronary intervention (PCI) has previously been reported to be associated with a worse outcome and Heart-type fatty acid binding protein (H-FABP) has recently been considered as a new predictor for myocardial injury in patients with coronary artery disease (CAD

Published
2020

4. PROGNOSTIC UTILITY OF TRIGLYCERIDE RICH LIPOPROTEINS RELATED MARKERS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE ON STATIN THERAPY

Author

Chuan-Que Cui, Yan Zhang, Hui-Wen Zhang, Jian-Jun Li, Yuan-Lin Guo, Hui-Hui Liu, Ying Gao, Yan-Fang Li, Ye-Xuan Cao, Na-Qiong Wu, Jing-Lu Jin, Geng Liu, Qian Dong, Jing Sun, Qi Hua, Cheng-Gang Zhu, and Rui-Xia Xu

Subjects
medicine.medical_specialty, Triglyceride, business.industry, Cholesterol, medicine.disease, Gastroenterology, Coronary artery disease, chemistry.chemical_compound, chemistry, Internal medicine, medicine, lipids (amino acids, peptides, and proteins), In patient, Statin therapy, Cardiology and Cardiovascular Medicine, Prospective cohort study, business, Lipoprotein
Abstract

Triglyceride-rich lipoproteins (TRL)-related markers, containing cholesterol subset [TRL-cholesterol (TRL-C) and remnant-like lipoprotein particles cholesterol (RLP-C)] and apolipopoprotein C-III (apoC-III), were reported to be involved in atherosclerosis. This multicenter prospective cohort study

Published
2020

5. LOW-DENSITY LIPOPROTEIN TRIGLYCERIDE AS A PROGNOSTIC PREDICTOR ASSOCIATES WITH DIFFERENT LOW DENSITY LIPOPROTEIN CHOLESTEROL TARGETS AND INFLAMMATORY STATUS IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE

Author

Ying Gao, Na-Qiong Wu, Jian-Jun Li, Hui-Wen Zhang, Yan Zhang, Yuan-Lin Guo, Cheng-Gang Zhu, Hui-Hui Liu, Rui-Xia Xu, Ye-Xuan Cao, Chuan-Jue Cui, Jing-Lu Jin, Qian Dong, and Jing Sun

Subjects
Coronary artery disease, medicine.medical_specialty, Endocrinology, Low density lipoprotein triglyceride, business.industry, Internal medicine, Medicine, Low density lipoprotein cholesterol, In patient, Cardiology and Cardiovascular Medicine, business, medicine.disease
Published
2020

6. ASSOCIATION OF LIPOPROTEIN(A) AND FIBRINOGEN AS PROGNOSTIC PREDICTORS FOR CARDIOVASCULAR OUTCOME IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE: A PROSPECTIVE, LARGE COHORT STUDY

Author

Hui-Hui Liu, Liu Geng, Yuan-Lin Guo, Jian-Jun Li, Ye-Xuan Cao, Na-Qiong Wu, Rui-Xia Xu, Hui-Wen Zhang, Yan Zhang, Gao Ying, Chuan-Jue Cui, Qian Dong, Jing Sun, and Jing-Lu Jin

Subjects
Plasma lipoprotein, medicine.medical_specialty, Antifibrinolytic, biology, medicine.drug_class, business.industry, Disease, Lipoprotein(a), Fibrinogen, medicine.disease, Large cohort, Coronary artery disease, Internal medicine, medicine, biology.protein, Cardiology, In patient, Cardiology and Cardiovascular Medicine, business, medicine.drug
Abstract

Elevated plasma lipoprotein(a) [Lp(a)] and fibrinogen (Fib) levels are both associated with cardiovascular disease (CVD) and the atherogenicity of Lp(a) can be partly due to the potentially antifibrinolytic categories. We hypothesize that patients with higher Lp(a) and Fib may have worse outcomes.

Published
2020

7. PREDICTING CARDIOVASCULAR OUTCOMES BY BASELINE LIPOPROTEIN(A) CONCENTRATIONS: A LARGE COHORT AND LONG-TERM STUDY ON REAL WORLD PATIENTS RECEIVING PCI

Author

Jing-Lu Jin, Jian-Jun Li, Na-Qiong Wu, Qi Hua, Ye-Xuan Cao, Yan-Fang Li, Yuan-Lin Guo, Cheng-Gang Zhu, Xie-Hui Chen, Hui-Wen Zhang, Hui-Hui Liu, and Rui-Xia Xu

Subjects
medicine.medical_specialty, biology, business.industry, medicine.medical_treatment, Percutaneous coronary intervention, Lipoprotein(a), Large cohort, Long term learning, Internal medicine, Conventional PCI, medicine, biology.protein, Cardiology, Cardiology and Cardiovascular Medicine, Baseline (configuration management), business, Cardiovascular outcomes, Lipoprotein
Abstract

Although several studies have indicated that lipoprotein(a) (Lp(a)) is a useful prognostic predictor for patients who underwent percutaneous coronary intervention (PCI), the previous observations have somewhat been limited by either small sample size or short-term follow-up. This study, hence, aimed

Published
2020

8. LONGITUDINAL ASSOCIATION OF LOW DENSITY LIPOPROTEIN TRIGLYCERIDE WITH CARDIOVASCULAR OUTCOMES IN PATIENTS WITH DIABETES AND PRE-DIABETES

Author

Jian-Jun Li, Ye-Xuan Cao, Yuan-Lin Guo, Hui-Wen Zhang, Rui-Xia Xu, Cheng-Gang Zhu, Jing-Lu Jin, Qian Dong, Jing Sun, Ying Gao, and Na-Qiong Wu

Subjects
medicine.medical_specialty, business.industry, Carbohydrate metabolism, medicine.disease, Low density lipoprotein triglyceride, Pre diabetes, Internal medicine, Diabetes mellitus, Stable cad, Cardiology, Medicine, lipids (amino acids, peptides, and proteins), In patient, cardiovascular diseases, Cardiology and Cardiovascular Medicine, business, Cardiovascular outcomes
Abstract

It has been well established that low density lipoprotein triglyceride (LDL-TG) is associated with hyperglycaemia. No current data, however, is available regarding the impact of LDL-TG on major adverse cardiovascular events (MACEs) in patients with stable CAD under different glucose metabolism

Published
2020

9. GW26-e4800 Relation of resistin to proprotein convertase subtilisin-kexin type 9 levels in coronary artery disease patients with different nutritional status

Author

Yuan-Lin Guo, Jian-Jun Li, Qian Dong, Yan Zhang, Geng Liu, Sha Li, Rui-Xia Xu, and Cheng-Gang Zhu

Subjects
medicine.medical_specialty, animal structures, business.industry, PCSK9, fungi, Subtilisin, nutritional and metabolic diseases, Nutritional status, Proprotein convertase, medicine.disease, digestive system, digestive system diseases, Coronary artery disease, Endocrinology, Internal medicine, Stable cad, medicine, cardiovascular system, Kexin, Resistin, cardiovascular diseases, Cardiology and Cardiovascular Medicine, business, hormones, hormone substitutes, and hormone antagonists
Abstract

To investigate the association of resistin with proprotein convertase subtilisin-kexin type 9 (PCSK9) levels, another novel regulator of atherosclerosis, in the condition of coronary artery disease (CAD). We prospectively enrolled a total of 356 consecutive stable CAD patients who were not treated

Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results